Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Neptune Technologies & Bioressources Inc T.NTB

Sector: Healthcare | Sub-Sector: Biotechnology

Neptune Technologies & Bioressources Inc is a biotechnology company engaged in the development, manufacture and commercialization of marine-derived omega-3 polyunsaturated fatty acids.
Price: $2.14 | Change: $-0.08 | %Change: -3.60%
Volume: 102,995 | Day High/Low: 2.31/2.10 | 52 Week High/Low: 4.08/1.99
View modes: 
0 stars

OpinionThe trial was designed about 4 years ago and at the t

The trial was designed about 4 years ago and at the time Likely 4 grams was considered a high dose because it was Krill not fish oil.  The 4 gram was pushed by Harlan Waksel and subsequently George...read more
3 stars

Conference call October 15th

Last Q's numbers won't be that great according to Godin due to customers waiting for the real deal NKO. The main importance of upcoming CC is for management to announce the resumption of NKO...read more
0 stars

End of quarter for funds

Today is end of the quarter for funds , so some shifting and window dressings are expected.  rate and reply
0 stars

RE:RE:RE:RE:NEWS!

The Q ending 8/31 will not have a good result. Andre Gordin already said that. It is due to the customers waited for the NKO products. The revenue will start go up from Q starting September. The SP...read more
0 stars

RE:RE:RE:NEWS!

Lets hope that financials on Oct. 13 will be good.  rate and reply
0 stars

RE:RE:NEWS!

This may be some MM's jumping ship now that the results are out and it's clear we're not getting a bounce.  The volume is low.  All I can think of here is many were expecting one prong of the...read more
0 stars

RE:NEWS!

What is so negative about this news? SP keeps going down.  rate and reply
0 stars

RE:RE:NEWS!

NTB owns approximately 50% of acasti. Used to be higher but Financing diluted it. Best  rate and reply
0 stars

RE:NEWS!

Goode news! " successful completion of the PK study" Neptune own Acasti at ???% Answer please  rate and reply
0 stars

NEWS!

http://www.stockhouse.com/news/press-releases/2014/09/30/acasti-announces-positive-top-line-pharmacokinetic-results  rate and reply
0 stars

RE:Conference call ?

Sean, I agree with you that the results outweigh Vascepa. The community will realise that soon enough. As for the CC, I am disappointed that the results weren't announced in that fashion to start with...read more
3 stars

RE:RE:RE:RE:Alex Ruus

Why do you even bother typing anything.. I wish someone would just put you / morningstar down, then I would havent to listening to you wine and compain over and over and over and over and over anover...read more
2 stars

RE:RE:RE:Alex Ruus

Don't blame Alex Ruus - he made his decision/opinion based on the information Neptune put out. All this lands on the company and it's management. I warned people about 9 months ago that the CEO had to...read more
5 stars

Conference call ?

Perhaps a conference call to discuss the results of Capre by Dr.Waksal would not be a bad idea. http://neptunekrilloil.com/neptune-forecasts-positive-future/  rate and reply
3 stars

RE:RE:Alex Ruus

"pounding the table buy" !!!!! lol  rate and reply
0 stars

RE:Alex Ruus

here we go....double or even quadrupel bagger....lol  rate and reply
2.5 stars

RE:RE:RE:RE:RE:RE:Acasti Reports Successful CaPre(R) Phase II TRIFECTA Results

the only winners in this company are the ones with the big paychecks and perks. Privately owned, they would be out of business long time ago!!!! What do we need a Chief Global Strategist for? What do...read more
3 stars

RE:RE:RE:RE:RE:Acasti Reports Successful CaPre(R) Phase II TRIFECTA Results

How about APO and NTB work on their press releases a little - if these numbers are truly out of the park results? I don't think they are given the trial I had thought was stopped earlier given the...read more
5 stars

RE:RE:RE:RE:Acasti Reports Successful CaPre(R) Phase II TRIFECTA Results

I am hearing from some that their concern is the apparent immaterial impact on levels of LDL-C, but LDL levels are not key according to Stephen Masley, MD and Fellow of the American Heart Association...read more
3 stars

RE:RE:RE:RE:RE:Acasti Reports Successful CaPre(R) Phase II TRIFECTA Results

goldstory, you want to see a" bit more aggressive marketing of NKO" ???? LOL There is no marketing of NKO!!!!!! This is called " The Goldstandard" LOL Investing in both of these company has been a...read more